Direxion Daily Energy Bull 2X Shares ETF
ERX
Direxion Daily Financial Bull 3X Shares ETF
FAS
Direxion Daily Real Estate Bull 3X Shares ETF
DRN
4
Ultra Financials Proshares
UYG
5
Energy Select Sector SPDR Fund
XLE
US Stock MarketDetailed Quotes
Connect Biopharma (CNTB)
- 2.050
- -0.030-1.44%
Close Jul 29 16:00 ET
- 2.090
- +0.040+1.95%
Post 19:34 ET
129.08MMarket Cap-1.78P/E (TTM)
2.105High2.010Low154.40KVolume2.100Open2.080Prev Close316.94KTurnover0.82%Turnover RatioLossP/E (Static)62.96MShares3.82052wk High3.03P/B38.64MFloat Cap1.23052wk Low--Dividend TTM18.85MShs Float29.274Historical High--Div Yield TTM4.57%Range %0.510Historical Low2.053Avg Price1Lot Size
CNTB Stock Chart
After-Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
CNTB Orderflow
Unit: --
CNTB Orderflow Trend
IntradayDayWeekMonth
No Data
Connect Biopharma (CNTB) News
Lake Street Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $9
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM) and Connect Biopharma Holdings (CNTB)
Oppenheimer Initiates Connect Biopharma(CNTB.US) With Buy Rating, Announces Target Price $8
Connect Biopharma Holdings (CNTB) Receives a New Rating From Oppenheimer
Connect Biopharma Shares Are Trading Higher After Oppenheimer Initiated Its Coverage on the Stock With a Outperform Rating and Announced a Price Target of $8.
Express News | Connect Biopharma Shares Are Trading Higher After Oppenheimer Initiated Its Coverage on the Stock With a Outperform Rating and Announced a Price Target of $8
Connect Biopharma (CNTB) Stock Forum
$Axe Compute (AGPU.US)$ 47.35%
$Xiao-I (AIXI.US)$ 102% ⭐️RUNNER
$Connect Biopharma (CNTB.US)$ 11.03%
$Cyclerion Therapeutics (CYCN.US)$ 44.52%
$Visionary Holdings (GV.US)$131.37% ⭐️RUNNER
$HMH Holding (HMH.US)$ 16.56%
$Nexera Technologies (NEXR.US)$ 64.06%
$SEMILUX INTERNATIONAL LTD (SELXF.US)$ 54.29%
$U Power (UCAR.US)$ 27.10%
$Xiao-I (AIXI.US)$ 102% ⭐️RUNNER
$Connect Biopharma (CNTB.US)$ 11.03%
$Cyclerion Therapeutics (CYCN.US)$ 44.52%
$Visionary Holdings (GV.US)$131.37% ⭐️RUNNER
$HMH Holding (HMH.US)$ 16.56%
$Nexera Technologies (NEXR.US)$ 64.06%
$SEMILUX INTERNATIONAL LTD (SELXF.US)$ 54.29%
$U Power (UCAR.US)$ 27.10%
27
4
3
$Connect Biopharma (CNTB.US)$ James Huang completed an open market purchase of 1.16 million ordinary shares of Connect Biopharma on 03/31/2026 at $3.45 per share, totaling approximately $4 million. The transaction was conducted indirectly.
1
$Connect Biopharma (CNTB.US)$ insider
1
$Connect Biopharma (CNTB.US)$
Connect Biopharma Announces $20.2 Million Private Placement Financing
Monday, 30th March at 7:02 am
Funding from new and existing investors extends anticipated cash runway into the second half of 2027
SAN DIEGO, March 30, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (NASDAQ: CNTB) ("Connect Biopharma," "Connect" or the "Company"), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory disea...
Connect Biopharma Announces $20.2 Million Private Placement Financing
Monday, 30th March at 7:02 am
Funding from new and existing investors extends anticipated cash runway into the second half of 2027
SAN DIEGO, March 30, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (NASDAQ: CNTB) ("Connect Biopharma," "Connect" or the "Company"), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory disea...
$Connect Biopharma (CNTB.US)$ Reuters
2m
Connect Biopharma Announces $20.2 Million Private Placement Financing
Connect Biopharma Announces Positive Topline Data From Its Phase 1 Study of Intravenous (IV) Rademikibart in Patients With Asthma or Copd
Connect Biopharma Holdings Ltd - Rademikibart Well-Tolerated With No Serious or Severe Adverse Events
2m
Connect Biopharma Announces $20.2 Million Private Placement Financing
Connect Biopharma Announces Positive Topline Data From Its Phase 1 Study of Intravenous (IV) Rademikibart in Patients With Asthma or Copd
Connect Biopharma Holdings Ltd - Rademikibart Well-Tolerated With No Serious or Severe Adverse Events
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)
Blvckwood : thanks your posts help alot
Riyan5426 : Thank you![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
76338690 : thank you
SPACE GHOST 7777 :
